The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

DOI: 10.4244/EIJ-D-19-00566

1. Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands.
2. Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
3. Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
4. Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands.
5. Department of Interventional Cardiology, Cardiovascular Institute, University Clinic Hospital, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
6. Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands; Cardialysis B.V, Rotterdam, the Netherlands
7. NHLI, Imperial College London, London, UK, UNITED KINGDOM
Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention and external reviewers - has been published immediately upon acceptance as it was received in the last round of revision. The content of this article is the responsibility of the authors.

Please note that supplementary movies are not available online at this stage. Once a paper is published in its edited and formatted form, it will be accompanied online by any supplementary movies.

To read the full content of this article, please log in to download the PDF.

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Impact of horizontal aorta on procedural and clinical outcomes in second-generation transcatheter aortic valve implantation